HMGCR and metabolic dysfunction-associated steatotic liver disease: Given the association between NAFLD patients with obesity and dysregulated metabolic syndrome who are at high risk for nonviral HCC, it is plausible that there may be similarities in the phosphorylation and dephosphorylation of HMGCR between NAFLD and HCC patients.